Boryung eying sales of 100 billion won with new drug

Published: 2010-09-10 06:58:00
Updated: 2010-09-10 06:58:00
Boryung Pharmaceutical Co. said its 74 newly recruited salespersons have been under intensive product training for Kanarb (fimasartan), a new drug for hypertension.

The company filed an application with the country's health watchdog last March to market Kanar in a bid to raise 100 billion won ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.